Search results
19 hours ago · He joins other luminaries on our Medical Advisory Board who also believe in our stem-cell based therapy’s potential to offer hope and better results for those with cancer,” said Allan Camaisa ...
Jun 27, 2024 · “Dr. Peoples is a highly esteemed figure in the field of cancer immunotherapy, bringing decades of experience in cancer vaccine development and clinical research to our Board,” said Allan Camaisa, CEO and Chairman of the Board of Calidi Biotherapeutics.
19 hours ago · Calidi's CEO, Allan Camaisa, highlighted Dr. Gilbert's expertise in developing multi-institutional studies and partnerships with national centers of excellence, which could advance Calidi's research efforts.
7 hours ago · Mr. Camaisa added, “Dr Gilbert’s expertise and experience will aid in guiding us on developing innovative, multi-institutional studies, partnering with national centers of excellence and key components of the NCI and NIH through Cooperative Research Development Agreements (CRADAs) and other submissions.
Jul 7, 2024 · Calidi’s primary objective remains the advancement of its innovative immunotherapy pipeline. CEO Allan Camaisa emphasized the company's dedication to securing additional capital and continuing cost-cutting measures to propel its novel therapies aimed at eradicating solid tumors.
Jun 27, 2024 · “Dr. Peoples is a highly esteemed figure in the field of cancer immunotherapy, bringing decades of experience in cancer vaccine development and clinical research to our Board,” said Allan...
6 days ago · Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer.
